文献速递乳腺技术与安全PETCT

哺乳期乳腺生理性与高代谢性18F-FDG摄取在PET/CT上的表现

Physiologic and hypermetabolic breast 18-F FDG uptake on PET/CT during lactation.
PubMed 文献 · Eur Radiol · 2020-08-04

回顾性评估16例妊娠相关乳腺癌(PABC)哺乳期患者与16例无乳腺癌哺乳期对照者的18F-FDG-PET/CT数据,发现无乳腺癌哺乳期乳腺生理性摄取高(SUVmax=5.0±1.7),PABC患者非受累哺乳组织摄取较对照降低59%(p<0.0001),而肿瘤摄取高(SUVmax=7.8±7.2),可在背景上清晰显示。

要点

  • 无乳腺癌哺乳期乳腺生理性FDG摄取高(SUVmax=5.0±1.7),与年龄和哺乳时长无关。
  • PABC患者非受累哺乳组织FDG摄取较无乳腺癌哺乳对照降低59%(p<0.0001)。
  • PABC患者乳腺肿瘤FDG摄取高(SUVmax=7.8±7.2),在哺乳组织背景上可清晰显示。

关键影像表现/征象

  • 无乳腺癌哺乳期患者乳腺生理性摄取高,SUVmax=5.0±1.7(n=32侧乳腺),与除乳腺癌外的活动性恶性肿瘤状态无关。
  • PABC患者肿瘤FDG摄取高,SUVmax=7.8±7.2(n=16),较非受累哺乳组织SUVmax=2.1±1.1高326-643%。
  • PABC患者哺乳乳腺整体FDG摄取较无乳腺癌哺乳对照降低59%(p<0.0001)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the patterns of breast cancer-related and lactation-related 18F-FDG uptake in breasts of lactating patients with pregnancy-associated breast cancer (PABC) and without breast cancer.

METHODS: 18F-FDG-PET/CT datasets of 16 lactating patients with PABC and 16 non-breast cancer lactating patients (controls) were retrospectively evaluated. Uptake was assessed in the tumor and non-affected lactating tissue of the PABC group, and in healthy lactating breasts of the control group, using maximum and mean standardized uptake values (SUVmax and SUVmean, respectively), and breast-SUVmax/liver-SUVmean ratio. Statistical tests were used to evaluate differences and correlations between the groups.

RESULTS: Physiological uptake in non-breast cancer lactating patients' breasts was characteristically high regardless of active malignancy status other than breast cancer (SUVmax = 5.0 ± 1.7, n = 32 breasts). Uptake correlated highly between the two breasts (r = 0.61, p = 0.01), but was not correlated with age or lactation duration (p = 0.24 and p = 0.61, respectively). Among PABC patients, the tumors demonstrated high 18F-FDG uptake (SUVmax = 7.8 ± 7.2, n = 16), which was 326-643% higher than the mostly low physiological FDG uptake observed in the non-affected lactating parenchyma of these patients (SUVmax = 2.1 ± 1.1). Overall, 18F-FDG uptake in lactating breasts of PABC patients was significantly decreased by 59% (p < 0.0001) compared with that of lactating controls without breast cancer.

CONCLUSION: 18F-FDG uptake in lactating tissue of PABC patients is markedly lower compared with the characteristically high physiological uptake among lactating patients without breast cancer. Consequently, breast tumors visualized by 18F-FDG uptake in PET/CT were comfortably depicted on top of the background 18F-FDG uptake in lactating tissue of PABC patients.

KEY POINTS: • FDG uptake in the breast is characteristically high among lactating patients regardless of the presence of an active malignancy other than breast cancer. • FDG uptake in non-affected lactating breast tissue is significantly lower among PABC patients compared with that in lactating women who do not have breast cancer. • In pregnancy-associated breast cancer patients, 18F-FDG uptake is markedly increased in the breast tumor compared with uptake in the non-affected lactating tissue, enabling its prompt visualization on PET/CT.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Nissan N, Sandler I, Eifer M, et al. Physiologic and hypermetabolic breast 18-F FDG uptake on PET/CT during lactation. Eur Radiol. 2020. PMID: 32749586. doi:10.1007/s00330-020-07081-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。